Miglietta, F., Ragazzi, M., Fernandes, B., Griguolo, G., Massa, D., Bisagni, A., Bottosso, M., Porra, F., Gaudio, M., Iannaccone, D., Fassan, M., Lo Mele, M., Gasparini, E., Zarrilli, G., Coiro, S., Dore, L., Zambelli, A., Bisagni, G., Guarneri, V., & Dieci, M. (n.d.). a composite prognostic model for overall survival (OS) based on residual cancer burden (RCB) and tumor-infiltrating lymphocytes (TILs) on residual disease (RCB+TIL) in HER2+ breast cancer patients treated with neoadjuvant therapy: a multicenter study. European journal of cancer, 175, S3–. http://access.bl.uk/ark:/81055/vdc_100169755046.0x00002d